Hepatitis C Drugs Market was valued USD 18700 million and expected to reach USD 281.55 million by the end of forecasting period reflecting a sluggish CAGR of 1.17% by 2030. Hepatitis C, a viral infection affecting the liver, has long posed a significant global health challenge. However, advancements in medical science, particularly in the development of Hepatitis C drugs, have transformed the...